DE69530787D1 - Auf die leber zielende verbindungen und reagentien zu deren herstellung - Google Patents

Auf die leber zielende verbindungen und reagentien zu deren herstellung

Info

Publication number
DE69530787D1
DE69530787D1 DE69530787T DE69530787T DE69530787D1 DE 69530787 D1 DE69530787 D1 DE 69530787D1 DE 69530787 T DE69530787 T DE 69530787T DE 69530787 T DE69530787 T DE 69530787T DE 69530787 D1 DE69530787 D1 DE 69530787D1
Authority
DE
Germany
Prior art keywords
hexose
compounds
directed
hepatic
configuration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69530787T
Other languages
English (en)
Other versions
DE69530787T2 (de
Inventor
Louis J Theodore
Donald B Axworthy
John M Reno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poniard Pharmaceuticals Inc
Original Assignee
Poniard Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poniard Pharmaceuticals Inc filed Critical Poniard Pharmaceuticals Inc
Publication of DE69530787D1 publication Critical patent/DE69530787D1/de
Application granted granted Critical
Publication of DE69530787T2 publication Critical patent/DE69530787T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6893—Pre-targeting systems involving an antibody for targeting specific cells clearing therapy or enhanced clearance, i.e. using an antibody clearing agents in addition to T-A and D-M
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0465—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DE69530787T 1994-12-07 1995-12-06 Auf die leber zielende verbindungen und reagentien zu deren herstellung Expired - Fee Related DE69530787T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US351651 1989-05-15
US08/351,651 US5886143A (en) 1994-12-07 1994-12-07 Hepatic-directed compounds and reagents for preparation thereof
PCT/US1995/015875 WO1996017613A1 (en) 1994-12-07 1995-12-06 Hepatic-directed compounds and reagents for preparation thereof

Publications (2)

Publication Number Publication Date
DE69530787D1 true DE69530787D1 (de) 2003-06-18
DE69530787T2 DE69530787T2 (de) 2004-06-03

Family

ID=23381756

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69530787T Expired - Fee Related DE69530787T2 (de) 1994-12-07 1995-12-06 Auf die leber zielende verbindungen und reagentien zu deren herstellung

Country Status (7)

Country Link
US (2) US5886143A (de)
EP (1) EP0794788B1 (de)
JP (1) JP2001525790A (de)
AT (1) ATE240109T1 (de)
CA (1) CA2207096A1 (de)
DE (1) DE69530787T2 (de)
WO (1) WO1996017613A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3664727B2 (ja) * 1994-01-24 2005-06-29 ネオルクス コーポレイション 放射標識したアネキシン
US5968477A (en) * 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
US6172045B1 (en) * 1994-12-07 2001-01-09 Neorx Corporation Cluster clearing agents
EP0906015A4 (de) * 1996-06-06 2004-05-12 Neorx Corp Mittel zur unterdrückung von rückhalteprozessen in der leber
DE19755367C2 (de) * 1997-12-12 2001-03-22 Afting Ernst Guenter Pharmazeutische Zusammensetzung enthaltend D-Galaktose und ihre Verwendung
MXPA01004239A (es) * 1998-10-30 2002-06-04 Daiichi Seiyaku Co Compuesto dds y metodo para la medicion del mismo.
KR20050038005A (ko) 2002-07-18 2005-04-25 헬릭스 바이오파마 코포레이션 암세포 성장의 저해를 위한 우레아제의 사용
JP4430344B2 (ja) * 2002-09-09 2010-03-10 独立行政法人科学技術振興機構 多岐用途型リンカー化合物及びリガンド、並びにそれらの製造方法
WO2006041613A2 (en) * 2004-10-05 2006-04-20 Nanomega Medical Corporation Nanoparticles for targeting hepatoma cells
CA2591496C (en) * 2006-12-18 2014-09-02 Japan Science And Technology Agency Method of measuring interaction between biomaterial and sugar chain, method of evaluating biomaterial in sugar chain selectivity, method of screening biomaterial, method of patterning biomaterials, and kits for performing these methods
US9518087B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
RU2013133813A (ru) 2010-12-21 2015-01-27 Конинклейке Филипс Электроникс Н.В. Средства для выведения биомолекул из кровотока
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
JP6744227B2 (ja) 2014-02-21 2020-08-19 エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ（ウペエフエル）Ｅｃｏｌｅ Ｐｏｌｙｔｅｃｈｎｉｑｕｅ Ｆｅｄｅｒａｌｅ ｄｅ Ｌａｕｓａｎｎｅ （ＥＰＦＬ） 糖標的化治療剤
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
WO2018232176A1 (en) 2017-06-16 2018-12-20 The University Of Chicago Compositions and methods for inducing immune tolerance
KR20230006800A (ko) 2020-01-31 2023-01-11 아빌라 테라퓨틱스, 인크. 세포외 단백질의 분해를 위한 asgpr-결합 화합물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410688A (en) * 1981-04-29 1983-10-18 Allied Corporation Macromolecular highly branched homogeneous compound
US4568737A (en) * 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
US4558120A (en) * 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
US4507466A (en) * 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4587329A (en) * 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5045303A (en) * 1985-05-17 1991-09-03 Neorx Corporation Radiohalogenated small molecules for protein labeling
US5554386A (en) * 1986-07-03 1996-09-10 Advanced Magnetics, Inc. Delivery of therapeutic agents to receptors using polysaccharides
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
US4965392A (en) * 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
US5166320A (en) * 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
GB8809616D0 (en) * 1988-04-22 1988-05-25 Cancer Res Campaign Tech Further improvements relating to drug delivery systems
AU642202B2 (en) * 1989-12-27 1993-10-14 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
US5552525A (en) * 1991-02-08 1996-09-03 Diatech Inc. Technetium-99m labeled peptides for imaging inflammation
US5310536A (en) * 1992-02-06 1994-05-10 Mallinckrodt Medical, Inc. Ligands for improving metal chelate formation kinetics
US5624896A (en) * 1992-06-09 1997-04-29 Neorx Corporation Clearing agents useful in pretargeting methods

Also Published As

Publication number Publication date
US5985826A (en) 1999-11-16
EP0794788A1 (de) 1997-09-17
EP0794788A4 (de) 2000-05-24
EP0794788B1 (de) 2003-05-14
WO1996017613A1 (en) 1996-06-13
JP2001525790A (ja) 2001-12-11
ATE240109T1 (de) 2003-05-15
DE69530787T2 (de) 2004-06-03
US5886143A (en) 1999-03-23
CA2207096A1 (en) 1996-06-13

Similar Documents

Publication Publication Date Title
DE69530787D1 (de) Auf die leber zielende verbindungen und reagentien zu deren herstellung
US4224769B1 (de)
ID22994A (id) Senyawa aminoalkil glikosamina fosfat dan penggunaannya sebagai adjuvan dan pemicu kekebalan
DE3878023D1 (de) Planetengetriebesystem.
DE68911294T2 (de) Mikrobearbeiteter beschleunigungsmesser.
DE3875631T2 (de) System zur herstellung einer arbeitsumgebung.
DE3770242D1 (de) Kuebel fuer die pflanzenkultur.
DE3850919D1 (de) Diagnostisches Assay mit signalentwickelndem Agens auf dem Träger.
EP0251584A3 (de) Synchronisationsverwaltung für ein verteiltes Betriebssystem oder ähnliche Systeme
DE3751071D1 (de) Verpackung für landwirtschaftliche Produkte.
DE69203151T2 (de) System und Verfahren, um die auf den Schaltbereichswähler beschränkten Fehler zu tolerieren.
DE3788689T2 (de) Pflanzenwachstumsteigernde Rhizobakterien für landwirtschaftliche Nichtwurzelgetreide.
FI894257A0 (fi) Foerfarande foer framstaellning av ett optiskt aktivt system, i synnerhet att tillaempas pao ett fordons koerljus.
PT86690A (pt) Substituierte 3,4-dihydro-2h-benzopyrane verfahren zu ihrer herstellung ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
DE3863703D1 (de) Spielfreies planetengetriebe.
DE303553T1 (de) Hybrid zusammengestellter verdichter.
IT1237757B (it) Pannello prefabbricato con supporto vegetativo, particolarmente per muri di sostegno
ATE63556T1 (de) Makrolid-derivate, verfahren zu ihrer herstellung und ihre verwendung.
ATA156388A (de) Zapfwellengetriebe, insbesondere für die frontzapfwelle von ackerschleppern od. dgl.
DE69022342T2 (de) Planetengetriebesystem.
ES2171704T3 (es) Peptidos ciclicos analogos de somatostatina con actividad inhibidora sobre la hormona del crecimiento.
FI872943A0 (fi) Reaktor avsedd foer att alstra biogas.
FR2652134B1 (fr) Dispositif d'assemblage de tiges ou de tous autres elements longilignes tels que broches, cables, fils, barres, tiges ou autres.
ES2066422T3 (es) Expresion de un arn multigenes con actividad de autoempalme.
DE3581257D1 (de) Hybrid-samenproduktion bei gemeinem weizen durch gebrauch von cytoplasmischer maennlicher sterilitaet.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee